Hsu Jason
SEC CIK 1895035 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IMMX | Immix Biopharma, Inc. | Dir | 899.2K | $918.0K | — | 9 | 2021-12-20 | 2026-05-22 |
Most active insiders at IMMX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Morris Gabriel S | CFO, Dir | $5,067 | — |
| 2 | Rachman Ilya M | CEO, COB, Dir | $4,976 | — |
| 3 | Chudnovsky Yekaterina | Dir | — | — |
| 4 | Hsu Jason | Dir | — | — |
| 5 | Ng Carey | Dir | — | — |
| 6 | Marquet Magda | Dir | — | — |
| 7 | Adams Helen C. | Dir | — | — |
| 8 | BUCHAN JANE | Dir | — | — |
| 9 | CHANG NANCY T | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-29 17:05 | 2026-05-22 | IMMX | Immix Biopharma, Inc. | Hsu Jason | Dir | A - Grant | $0.00 | +6,250 | 899.2K | +0.7% | $0 |
| M | 2024-12-26 | 2024-12-20+ | IMMX | Immix Biopharma, Inc. | Hsu Jason | Dir | P - Purchase | $2.19 | +47.7K | 853.0K | +6% | +$104.3K |
| M | 2024-08-26 | 2024-08-21+ | IMMX | Immix Biopharma, Inc. | Hsu Jason | Dir | P - Purchase | $2.24 | +23.1K | 845.3K | +3% | +$51.7K |
| M | 2024-07-31 | 2024-07-18+ | IMMX | Immix Biopharma, Inc. | Hsu Jason | Dir | P - Purchase | $2.12 | +9,200 | 816.2K | +1% | +$19.5K |
| M | 2023-12-12 | 2023-12-08+ | IMMX | Immix Biopharma, Inc. | Hsu Jason | Dir | P - Purchase | $4.76 | +56.0K | 782.0K | +8% | +$266.8K |
| M | 2023-09-18 | 2023-09-11+ | IMMX | Immix Biopharma, Inc. | Hsu Jason | Dir | P - Purchase | $2.78 | +72.0K | 750.0K | +11% | +$200.4K |
| 2023-09-12 | 2023-09-08 | IMMX | Immix Biopharma, Inc. | Hsu Jason | Dir | P - Purchase | $2.53 | +10.0K | 685.0K | +1% | +$25.3K | |
| DI | 2021-12-20 | 2021-12-20 | IMMX | Immix Biopharma, Inc. | Hsu Jason | Dir | C - Cnv Deriv | $0.85 | +3.92M | 3.92M | New | +$3.33M |
| DI | 2021-12-20 | 2021-12-20 | IMMX | Immix Biopharma, Inc. | Hsu Jason | Dir | P - Purchase | $5.00 | +50.0K | 50.0K | New | +$250.0K |
Purchase Sale Sale after option exercise All abbreviations